Emerging Evidence for Neuropsycho-Consequences of COVID-19

Curr Neuropharmacol. 2021;19(1):92-96. doi: 10.2174/1570159X18666200507085335.

Abstract

The pandemic novel coronavirus disease (COVID-19) has become a global concern in which the respiratory system is not the only one involved. Previous researches have presented the common clinical manifestations including respiratory symptoms (i.e., fever and cough), fatigue and myalgia. However, there is limited evidence for neurological and psychological influences of SARS-CoV-2. In this review, we discuss the common neurological manifestations of COVID-19 including acute cerebrovascular disease (i.e., cerebral hemorrhage) and muscle ache. Possible viral transmission to the nervous system may occur via circulation, an upper nasal transcribrial route and/or conjunctival route. Moreover, we cannot ignore the psychological influence on the public, medical staff and confirmed patients. Dealing with public psychological barriers and performing psychological crisis intervention are an important part of public health interventions.

Keywords: Brain; COVID-19; SARS-COV-2; indirect influence; mental health; neurological; psychological; transmission.

Publication types

  • Review

MeSH terms

  • Blood-Brain Barrier
  • COVID-19 / physiopathology*
  • COVID-19 / psychology
  • COVID-19 / transmission
  • Central Nervous System Viral Diseases / physiopathology*
  • Central Nervous System Viral Diseases / psychology
  • Central Nervous System Viral Diseases / transmission
  • Cerebral Hemorrhage / physiopathology
  • Cerebrovascular Disorders / physiopathology*
  • Conjunctiva
  • Dizziness / physiopathology
  • Ethmoid Bone
  • Headache / physiopathology
  • Health Personnel / psychology
  • Humans
  • Myalgia / physiopathology*
  • Nervous System Diseases / physiopathology*
  • Nervous System Diseases / psychology
  • SARS-CoV-2